Alfredo Sánchez-Hernández

Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials

Renata Ferrarotto, Ian C. Anderson, Balazs Medgyasszay et al. · Cancer Medicine · 2021 · 48 citations · Full text

Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non–Small Cell Lung Cancer With High Tumor Mutation Burden

Mariano Provencio, Ana Laura Ortega Granados, Juan Coves-Sarto et al. · JAMA Oncology · 2022 · 42 citations · Full text

Analysis of circulating tumour DNA to identify patients with epidermal growth factor receptor–positive non-small cell lung cancer who might benefit from sequential tyrosine kinase inhibitor treatment

Mariano Provencio, Roberto Serna‐Blasco, V. Blázquez Calvo et al. · European Journal of Cancer · 2021 · 30 citations · Full text

Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program

Daniel Castellano, Luis Aparicio, Emilio Esteban et al. · Expert Opinion on Drug Safety · 2014 · 28 citations · Full text

Intercalated Dosing Schedule of Erlotinib and Docetaxel as a Therapeutic Strategy to Avoid Antagonism and Optimize Its Benefits in Advanced Non–Small-Cell Lung Cancer. A Randomized Phase II Clinical Trial

Óscar Juan, Francisco Aparisi, Alfredo Sánchez-Hernández et al. · Clinical Lung Cancer · 2014 · 14 citations

Oncology, Medicine, Dosing Schedule +6